alphaveLINCOLN₹636.70

Lincoln Pharmaceuticals Limited

₹ CrorePeersSIGACHI THEMISMED BAJAJHCARE AMRUTANJANJAGSNPHARM WANBURY AHCLMcap ₹1,275 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	179.0	181.5	190.0	190.0
+ Capital Work-in-Progress	3.5	4.5	5.2	5.2
+ Other Intangibles	0.3	0.4	0.9	0.9
+ Non-current Investments	0.0	0.0	0.0	0.0
+ Long-term Loans	65.8	106.0	106.9	106.9
+ Other Non-current Financial Assets	0.6	1.1	1.3	1.3
Non-current Financial Assets	66.4	107.1	108.3	108.3
+ Other Non-current Assets	4.4	3.6	2.9	2.9
Total Non-current Assets	253.6	297.1	307.3	307.3
Current Assets
+ Inventories	77.2	78.7	80.1	80.1
+ Current Investments	138.9	173.7	208.5	208.5
+ Trade Receivables	161.8	166.4	161.4	161.4
+ Cash & Cash Equivalents	5.7	13.4	21.5	21.5
+ Other Bank Balances	8.1	9.0	11.1	11.1
+ Short-term Loans	38.4	35.3	80.9	80.9
+ Other Current Financial Assets	0.5	1.2	0.8	0.8
Current Financial Assets	353.5	399.0	484.3	484.3
+ Other Current Assets	16.1	21.6	18.7	18.7
Total Current Assets	446.7	499.9	583.1	583.1
Total Assets	700.3	797.0	890.4	890.4
Equity
+ Equity Share Capital	20.0	20.0	20.0	20.0
+ Other Equity / Reserves	572.8	651.6	737.6	737.6
Equity — Owners of Parent	592.8	671.7	757.6	757.6
Total Equity	592.8	671.7	757.6	757.6
Liabilities
+ Other Non-current Financial Liab	3.6	5.4	6.4	6.4
Non-current Financial Liabilities	3.6	5.4	6.4	6.4
+ Provisions — Non-current	0.1	0.7	1.8	1.8
+ Deferred Tax Liabilities	11.5	13.0	13.5	13.5
Non-current Liabilities	15.2	19.1	21.7	21.7
+ Borrowings — Current	1.1	0.0	4.4	4.4
+ Trade Payables	72.4	84.9	84.9	84.9
+ Other Current Financial Liab	12.4	9.7	11.1	11.1
Current Financial Liabilities	85.9	94.6	100.4	100.4
+ Provisions — Current	3.5	6.5	6.1	6.1
+ Current Tax Liabilities	0.1	0.0	1.7	1.7
+ Other Current Liabilities	2.7	5.1	2.9	2.9
Current Liabilities	92.3	106.2	111.0	111.0
Total Liabilities	107.5	125.3	132.8	132.8
Total Equity & Liabilities	700.3	797.0	890.4	890.4
Assets — additional as-filed lines
+ Current Tax Assets	0.0	0.7	0.0	0.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	8.7	6.9	6.9
+ Dues to Other Creditors — Current	—	76.2	77.9	77.9

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.